InvestorsHub Logo
Post# of 252524
Next 10
Followers 30
Posts 4142
Boards Moderated 0
Alias Born 07/25/2007

Re: biomaven0 post# 141367

Sunday, 05/06/2012 1:31:34 PM

Sunday, May 06, 2012 1:31:34 PM

Post# of 252524
Peter,

Ganetespib also failed to meet its endpoints as a single agent in metastatic breast cancer, although signs of effectiveness were seen in certain sub-groups.

http://www.syntapharma.com/Documents/Ganetespib_Ph2_MBC_SABCC_2011_Poster.pdf


I wold be pretty surprised if SNTA made a substantial effort to use Ganetespib as a single agent in future trials.

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.